Exploring the Impact of Obesity on Skeletal Muscle Function in Older Age
Overview
Authors
Affiliations
Sarcopenia is of important clinical relevance for loss of independence in older adults. The prevalence of obesity in combination with sarcopenia ("sarcopenic-obesity") is increasing at a rapid rate. However, whilst the development of sarcopenia is understood to be multi-factorial and harmful to health, the role of obesity from a protective and damaging perspective on skeletal muscle in aging, is poorly understood. Specifically, the presence of obesity in older age may be accompanied by a greater volume of skeletal muscle mass in weight-bearing muscles compared with lean older individuals, despite impaired physical function and resistance to anabolic stimuli. Collectively, these findings support a potential in which obesity may protect skeletal muscle mass in older age. One explanation for these paradoxical findings may be that the anabolic response to weight-bearing activity could be greater in obese vs. lean older individuals due to a larger mechanical stimulus, compensating for the heightened muscle anabolic resistance. However, it is likely that there is a complex interplay between muscle, adipose, and external influences in the aging process that are ultimately harmful to health in the long-term. This narrative briefly explores of the potential mechanisms regulating changes in skeletal muscle mass and function in aging combined with obesity and the interplay with sarcopenia, with a particular focus on muscle morphology and the regulation of muscle proteostasis. In addition, whilst highly complex, we attempt to provide an updated summary for the role of obesity from a protective and damaging perspective on muscle mass and function in older age. We conclude with a brief discussion on treatment of sarcopenia and obesity and a summary of future directions for this research field.
The role of autoantibodies in bridging obesity, aging, and immunosenescence.
Valentino T, Chen N, Makhijani P, Khan S, Winer S, Revelo X Immun Ageing. 2024; 21(1):85.
PMID: 39616399 PMC: 11607830. DOI: 10.1186/s12979-024-00489-2.
Guandalini V, Tofani P, Souza Lima S, Coelho Silveira L, Cochar-Soares N, Barros Pereira da Silva T Aging Clin Exp Res. 2024; 36(1):222.
PMID: 39557762 PMC: 11573834. DOI: 10.1007/s40520-024-02866-9.
Arteaga-Pazmino C, Fonseca-Perez D, Balladares Mazzini M, Galvez-Celi J, Emen Sanchez J, Alvarez-Cordova L Front Nutr. 2024; 11:1480284.
PMID: 39385775 PMC: 11461314. DOI: 10.3389/fnut.2024.1480284.
Mabe-Castro D, Castillo-Aguilar M, Mabe-Castro M, Mendez Munoz R, Basualto-Alarcon C, Nunez-Espinosa C PeerJ. 2024; 12:e18061.
PMID: 39346081 PMC: 11439397. DOI: 10.7717/peerj.18061.
Simon A, Derella C, Looney J, Norland K, Wang X, Harris R Endocrinol Diabetes Metab. 2024; 7(5):e513.
PMID: 39141578 PMC: 11324093. DOI: 10.1002/edm2.513.